• DNA with UConn Health building
    Created in 1998, the Department of Genetics and Genome Sciences, formerly Genetics and Developmental Biology, offers new and exciting opportunities for research and graduate education.

Welcome

Brenton R. Graveley, Ph.D.

Welcome to the Department of Genetics and Genome Sciences. Created in 1998, the department offers many exciting opportunities for research and graduate education. The department is located in the state-of-the-art Cell and Genome Sciences Building. The department is also the academic home of the Division of Medical Genetics which provides clinical and laboratory genetics services to Connecticut. Our research strengths include RNA biology, developmental biology, signal transduction, and the genetic and epigenetic mechanisms of gene regulation. We are continually increasing external funding for our current research programs, enhancing the national and international reputation of our faculty and their research, and recruiting outstanding faculty members with new and complementary areas of research expertise. We also have a close working relationship with the Jackson Laboratory for Genomic Medicine (JAX-GM), and most JAX-GM faculty have academic appointments in our department. 
 
Dr. Brenton R. Graveley, Professor and Chair of Genetics and Genome Sciences, UConn School of Medicine, and Endowed Chair, Genomics and Personalized Healthcare; Director, UConn Stem Cell Institute and Associate Director, Institute for System Genomics, University of Connecticut.

Tenure-Track Faculty Position

The Department invites applications for a tenure-track faculty position at the Assistant/Associate Professor level (position #2019-069). Successful applicants will have the opportunity to participate in a highly interactive culture within the department, with our close colleagues at The Jackson Laboratory, and the UConn Institute for Systems Genomics. The ideal candidate is expected to complement existing strengths in the department with an robust research program focused on a cutting-edge area of contemporary genetics and/or genomics. Areas of interest include, but are not limited to single-cell genomics, RNA genomics, epigenetics, genome editing and engineering, synthetic genomics, genome technology, and computational genomics.

Se-Jin Lee inducted into CASE

Se-Jin Lee, M.D., Ph.D.Presidential Distinguished Professor Se-Jin, an internationally renowned geneticist focused on discovering causes and cures for muscle degenerative diseases like muscular dystrophy and muscle wasting conditions that result from diseases such as cancer and sepsis, has been inducted into the Connecticut Academy of Science and Engineering (CASE). Breakthrough research includes the discovery of myostatin, a protein that blocks muscle growth (Link to UConn Today).

Next Generation Venture Capitalist Training at UConn School of Medicine

Blanka Rogina, Ph.D., was appointed by Dr. Bruce Liang, Dean of the UConn School of Medicine, to Chair the UConn-Canaan Fellowship Program Committee. This program provides our students hands-on training for real life, venture capital projects. (read more)

UConn-Wesleyan Stem Cell Core: Past, Present, and Future

A collaborative effort between UConn, Wesleyan, and The Jackson Laboratory for Genomic Medicine has been contributing a wealth of research to the field of stem cell science since its inception in 2006 during a time when the federal government had instituted a ban on projects using stem cells (read more).

Precision Medicine World Conference Speaker Spotlight

Zeeshan Ahmed, Ph.D.Dr. Zeeshan Ahmed's research is focused on the development of intelligent big data analytics platforms to improve the quality and transition of healthcare for investigating heterogeneous clinical data to obtain actionable care gap-based information about patients for early detection and prevention of constitutional disorders and cancer, and developing efficient communication across healthcare units and scientific labs (interview link).

Inaugural Fellow, UConn-Canaan Fellowship Program

Congratulations to Scott Adamson who was selected to participate in the UConn-Canaan Fellowship Program. Students selected receive hands-on training from Canaan Partners, a multi-billion dollar venture capital firm. Scott is currently a Ph.D. student in the Graveley lab. His research focuses on developing and utilizing high-throughput reporter assays in order to study the genetic variants can impact pre-mRNA splicing.